We are live on ! Find out more

Micro Cap Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
TRAW icon
226
Traws Pharma
TRAW
$7.36M
$7.36M $0.4790 7.88%
SKYE icon
227
Skye Bioscience
SKYE
$7.31M
$7.31M $1.65 1.85%
LEXX icon
228
Lexaria Bioscience
LEXX
$7.29M
$7.29M $3.46 6.79%
NRSN icon
229
NeuroSense Therapeutics
NRSN
$7.25M
$7.25M $3.82 6.14%
KALA icon
230
KALA BIO
KALA
$6.96M
$6.96M $0.3600 1.1%
BOLT icon
231
Bolt Biotherapeutics
BOLT
$6.93M
$6.93M $3.60 2.56%
CELZ icon
232
Creative Medical Technology
CELZ
$6.75M
$6.75M $0.8890 1.27%
ENVB icon
233
Enveric Biosciences
ENVB
$6.71M
$6.71M $1.50 2.04%
XCUR icon
234
Exicure
XCUR
$6.68M
$6.68M $1.02 5.56%
ALZN icon
235
Alzamend Neuro
ALZN
$6.61M
$6.61M $1.37 0%
CLGN icon
236
CollPlant Biotechnologies
CLGN
$6.54M
$6.54M $3.46 2.06%
EVGN icon
237
Evogene
EVGN
$6.49M
$6.49M $0.4106 3.09%
IMNN icon
238
Imunon
IMNN
$6.4M
$6.4M $1.14 1.79%
ENLV icon
239
Enlivex Ltd
ENLV
$6.1M
$6.1M $0.3064 9.94%
CDIO icon
240
Cardio Diagnostics
CDIO
$5.8M
$5.8M $1.96 2%
ACXP icon
241
Acurx Pharmaceuticals
ACXP
$5.59M
$5.59M $1.30 0.76%
DRMA icon
242
Dermata Therapeutics
DRMA
$5.55M
$5.55M $1.12 0.88%
ADXN
243
Addex Therapeutics
ADXN
$5.49M
$5.49M $3.13 1.57%
PULM icon
244
Pulmatrix
PULM
$5.44M
$5.44M $1.49 4.2%
LIMN
245
Liminatus Pharma
LIMN
$5.21M
$5.21M $3.88 4.86%
XBIO icon
246
Xenetic Biosciences
XBIO
$5.18M
$5.18M $2.21 4.25%
LNAI
247
Lunai Bioworks
LNAI
$4.94M
$4.94M $1.09 3.54%
PPCB
248
Propanc Biopharma
PPCB
$4.9M
$4.9M $0.4987 1.51%
XTLB
249
XTL Biopharmaceuticals
XTLB
$4.87M
$4.87M $1.98 1.98%
NCNA
250
NuCana
NCNA
$4.74M
$4.74M $1.14 4.59%
8 9
10
11 12

Micro Cap Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 288 micro cap Biotechnology stocks — companies in the Biotechnology industry with a market cap under $250M — worth a combined $20.1B.

The largest by market cap are Immuneering (IMRX) at $250M, Nautilus Biotechnolgy (NAUT) at $249M and Vicore Pharma Holding AB ADS (VCRE) at $244M.

Among institutional investors, Eledon Pharmaceuticals (ELDN) drew the most net new fund positions in Q2 2026: 51 funds opened new positions, taking total fund holders up 40 (33%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.